Detection of Mutant K-Ras DNA in Plasma or Serum of Patients With Colorectal Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1997.551
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Detection and Monitoring of Serum P53 Antibodies in Patients With Colorectal Cancer.

Gut
Gastroenterology
1997English

Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation

OncoTargets and Therapy
OncologyPharmacology
2013English

EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment

JCO Precision Oncology
Cancer ResearchOncology
2018English

Serum Concentrations of Soluble Adhesion Molecules in Patients With Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Detection of Mutant BRAF Alleles in the Plasma of Patients With Metastatic Melanoma

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2007English

Detection of Bacterial DNA in Serum From Colon Cancer Patients: Association With Cytokine Levels and Cachexia

journal of Cancer Therapeutics and Research
2012English

Detection of Aberrant Promoter Methylation of RNF180, DAPK1 and SFRP2 in Plasma DNA of Patients With Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy